首页> 外文期刊>Biosciences Biotechnology Research Asia >The Inhibitory Effect of Itraconazole on Atherosclerosis in Hyperlipidemic Rabbits
【24h】

The Inhibitory Effect of Itraconazole on Atherosclerosis in Hyperlipidemic Rabbits

机译:伊曲康唑对高脂血症兔动脉粥样硬化的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

Atherosclerosis is a chronic inflammatory disease of the great vessels. The drug Itraconazole, with a full antifungal range has the following important properties: antiinflammatory feature, its inhibitory effect on the activity of S-lipoxygenase and Chemotaxis of T-cell and the production of leukotriene, its effect on stopping VEGF, its decreasing effect on LDL -C and its increasing effect on the HDL -C and IL-10. 40 rabbits were divided into 4 equal groups. The day before the experiment the animalswere bled and then the first group was fed standard food, the second group was fed a high-cholesteroldiet, the third group was fed standard food and Itraconazole and the fourth group was fed a high-cholesterol diet and Itraconazole, at the end of the twelfth week the animals were bled and information was reviewed. Significant reduction in serum levels of TC, TG and LDL-C and a significant increase in HDL-C in the fourth group compared to the second group at the end of the experiment, indicates the effectiveness of this drug on the adjustment mode of Dyslipidemia caused by the consumption of high cholesterol foods. In the third group compared to the control group, triglyceride, total cholesterol and LDL-C have significantly reduced and HDL-C was significantly increased, which indicates the negative effect of drug with a dose of 80 mg per kg at the end of the twelfth week (05 / OP <). Itraconazole by reducing serum level of cholesterol will slow the process of Atherosclerosis.
机译:动脉粥样硬化是大血管的慢性炎性疾病。具有广泛抗真菌作用的药物伊曲康唑具有以下重要特性:抗炎特性,对S-脂氧合酶活性和T细胞趋化性的抑制作用以及白三烯的产生,对VEGF的抑制作用,对VEGF的降低作用LDL -C及其对HDL -C和IL-10的增加作用。将40只兔子分成4等份。在实验的前一天给动物放血,然后第一组喂食标准食物,第二组喂食高胆固醇食物,第三组喂食标准食物和伊曲康唑,第四组喂食高胆固醇饮食和伊曲康唑在第十二周结束时,将动物放血并检查信息。在实验结束时,与第二组相比,第四组的血清TC,TG和LDL-C水平显着降低,而HDL-C显着升高,表明该药物对血脂异常调节模式的有效性通过食用高胆固醇食物。与对照组相比,第三组甘油三酸酯,总胆固醇和LDL-C显着降低,HDL-C显着升高,这表明在第十二个末期,每公斤80 mg剂量的药物产生了负面影响周(05 / OP <)。伊曲康唑可通过降低血清胆固醇水平来减缓动脉粥样硬化的进程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号